Posted in

PNEUMONIA—LUNG INFLAMMATION AND FLUID IN ALVEOLI – Self learning Lecture # 3, Page # 554 Chapter # 43.

PNEUMONIA—LUNG INFLAMMATION AND FLUID IN ALVEOLI -Superfast self learning series-3, Page # 554, Guyton physiology 15th Edition.

Definition

  • Pneumonia is an inflammatory disease of the lungs.
  • In pneumonia, some or all of the alveoli become filled with fluid and blood cells instead of air. (Fig. 43.5)
  • This filling of the alveoli interferes with normal gas exchange.

Bacterial Pneumonia

  • A common type is bacterial pneumonia, which is most often caused by pneumococci.

Development of the Disease

  • The infection begins in the alveoli.
  • The pulmonary (alveolar) membrane becomes inflamed.
  • Because of inflammation, the membrane becomes highly porous (more permeable).
  • As a result:
    • Fluid leaks from the blood into the alveoli.
    • Red blood cells leak into the alveoli.
    • White blood cells also enter the alveoli to fight the infection.
  • Consequently, the infected alveoli gradually fill with fluid and inflammatory cells.
  • The infection spreads from one alveolus to another through the movement of bacteria or viruses.
  • As the disease progresses:
    • Large areas of the lung may become involved.
    • Sometimes an entire lobe or even a whole lung is affected.
  • These affected regions become consolidated, meaning they are:
    • Filled with fluid.
    • Filled with inflammatory cells and cellular debris.
    • Unable to participate effectively in gas exchange.

Effect on Gas Exchange

  • In pneumonia, the gas exchange function of the lungs gradually decreases as the disease progresses.

Early Stage

  • In the early stage, only one lung or one part of a lung may be affected.
  • In the diseased area:
    • Alveolar ventilation decreases because the alveoli are filled with fluid.
    • Blood flow continues normally through the pulmonary capillaries.

Major Pulmonary Abnormalities

1. Reduced Respiratory Membrane Surface Area

  • Fluid-filled alveoli cannot participate effectively in gas exchange.
  • Therefore, the total surface area available for diffusion decreases.
  • This reduces the exchange of oxygen and carbon dioxide.

2. Decreased Ventilation–Perfusion (V̇A/Q̇) Ratio

  • The affected alveoli receive little or no ventilation.
  • However, blood continues to flow through their capillaries.
  • This causes a decreased ventilation–perfusion (V̇A/Q̇) ratio.
  • Because blood passes through poorly ventilated alveoli, it:
    • Receives less oxygen.
    • Removes less carbon dioxide.
  • As a result:
    • Hypoxemia develops (low oxygen level in the blood).
    • Hypercapnia develops (high carbon dioxide level in the blood).

Oxygen Saturation in Pneumonia

  • Fig. 43.6 illustrates the effect of a low V̇A/Q̇ ratio.
  • Blood flowing through the normal (aerated) lung becomes approximately 97% saturated with oxygen.
  • Blood flowing through the affected (unaerated) lung becomes only about 60% saturated with oxygen.
  • When these two blood streams mix in the left side of the heart, the average arterial oxygen saturation falls to about 78%.
  • This oxygen saturation is far below the normal level, resulting in significant hypoxemia.

KEY CONCEPT

  • Pneumonia is inflammation of the lungs in which alveoli become filled with fluid and blood cells (Fig. 43.5).
  • Bacterial pneumonia is most commonly caused by pneumococci.
  • Inflammation increases alveolar membrane permeability, allowing fluid, red blood cells, and white blood cells to enter the alveoli.
  • The infection spreads from alveolus to alveolus, and large lung areas may become consolidated with fluid and cellular debris.
  • Pneumonia reduces gas exchange by decreasing the respiratory membrane surface area and lowering the ventilation–perfusion (V̇A/Q̇) ratio.
  • These changes produce hypoxemia (low blood O₂) and hypercapnia (high blood CO₂).
  • Blood from normal alveoli is about 97% oxygen saturated, whereas blood from fluid-filled alveoli is only about 60% saturated; after mixing, arterial oxygen saturation falls to about 78% (Fig. 43.6).

ATELECTASIS—COLLAPSE OF THE ALVEOLI

Definition

  • Atelectasis means collapse of the alveoli.
  • It may involve:
    • A small (localized) area of the lung, or
    • An entire lung.

Common Causes of Atelectasis

The two most common causes are:

  1. Complete obstruction of an airway.
  2. Lack of surfactant in the fluid lining the alveoli.

Airway Obstruction Causes Lung Collapse

Causes of Airway Obstruction

Airway obstruction usually occurs because of:

  • Blockage of many small bronchi by mucus, or
  • Blockage of a major bronchus by a large mucus plug or a solid object such as a tumor.

What Happens After Airway Obstruction?

  • Air becomes trapped in the alveoli beyond the obstruction.
  • This trapped air is gradually absorbed into the blood flowing through the pulmonary capillaries.
  • Absorption usually occurs within minutes to hours.

If the Lung Is Pliable (Flexible)

  • If the lung tissue is soft and flexible, the alveoli simply collapse after the trapped air is absorbed.
  • This produces atelectasis.

If the Lung Is Rigid

  • If the lung is stiff because of fibrotic tissue, it cannot collapse easily.
  • As the trapped air is absorbed:
    • Very negative pressure develops inside the alveoli.
    • This negative pressure pulls fluid from the pulmonary capillaries into the alveoli.
  • Consequently, the alveoli become completely filled with edema fluid.
  • When an entire lung collapses, this condition is called massive collapse of the lung.

Effects of Massive Atelectasis on Pulmonary Function

(Fig. 43.7 given above )

1. Collapse of Alveoli

  • The collapsed lung tissue closes the alveoli, preventing ventilation.

2. Increased Pulmonary Vascular Resistance

  • Lung collapse compresses and folds the pulmonary blood vessels.
  • This increases resistance to blood flow through the affected lung.
  • In addition:
    • Hypoxia in the collapsed alveoli causes pulmonary vasoconstriction.
  • Therefore, pulmonary vascular resistance increases even further.

3. Blood Flow Is Redirected

  • Because vascular resistance increases, much less blood flows through the collapsed lung.
  • Most of the blood is redirected to the healthy, ventilated lung.
  • This helps maintain better oxygenation.
  • In the example shown in Fig. 43.7:
    • Five-sixths of the blood flows through the ventilated lung.
    • Only one-sixth flows through the collapsed (unventilated) lung.

4. Ventilation–Perfusion Relationship

  • Although one lung receives no ventilation, most blood is diverted to the functioning lung.
  • Therefore:
    • The overall ventilation–perfusion (V̇A/Q̇) ratio is only moderately reduced.
    • Arterial oxygen saturation decreases only slightly (mild O₂ desaturation) despite complete collapse of one lung.

KEY CONCEPT

  • Atelectasis is the collapse of alveoli and may involve part of a lung or an entire lung.
  • The two major causes are complete airway obstruction and lack of surfactant.
  • Airway obstruction allows trapped air to be absorbed into the blood, leading to alveolar collapse within minutes to hours.
  • If the lung is rigid and cannot collapse, negative alveolar pressure draws fluid into the alveoli, producing pulmonary edema.
  • Massive atelectasis increases pulmonary vascular resistance because lung collapse compresses blood vessels and hypoxia causes pulmonary vasoconstriction (Fig. 43.7). (given above )
  • Most blood is redirected to the normal lung (about five-sixths), while only one-sixth passes through the collapsed lung.
  • As a result, the overall V̇A/Q̇ ratio is only moderately impaired, and arterial oxygen desaturation is usually mild despite complete collapse of one lung.

LACK OF SURFACTANT AS A CAUSE OF LUNG COLLAPSE

Normal Role of Surfactant

  • Surfactant is secreted by special alveolar epithelial cells.
  • It is released into the fluid lining the inner surface of the alveoli.
  • Surfactant reduces the surface tension of alveolar fluid by 2–10 times.
  • By lowering surface tension, surfactant helps keep the alveoli open during breathing.
  • Therefore, surfactant plays a major role in preventing alveolar collapse.

Surfactant Deficiency

  • In some conditions, the amount of surfactant produced by the alveoli is greatly reduced.
  • One important example is hyaline membrane disease, also called respiratory distress syndrome (RDS).
  • This condition commonly occurs in premature newborn infants.
  • Because too little surfactant is present:
    • Surface tension of the alveolar fluid becomes several times higher than normal.
    • The alveoli have a strong tendency to collapse (atelectasis).
    • The alveoli may also fill with fluid.

Effects of Surfactant Deficiency

  • Large portions of the lungs may collapse (atelectasis).
  • As more alveoli collapse:
    • Ventilation decreases markedly.
    • Gas exchange becomes severely impaired.
    • The infant develops severe respiratory distress.
  • Without treatment:
    • Many premature infants die from suffocation because large areas of the lungs become atelectatic.

Treatment

  • Survival of premature infants has improved greatly with:
    • Surfactant replacement therapy.
    • Assisted mechanical ventilation.
    • Administration of corticosteroids before birth.
    • Other supportive treatments.
  • Despite these advances, hyaline membrane disease remains an important cause of illness (morbidity) and death (mortality) in premature infants.
  • The more premature the infant, the more severe the respiratory distress.

KEY CONCEPT

  • Surfactant is produced by alveolar epithelial cells and lines the inner surface of the alveoli.
  • It reduces alveolar surface tension by 2–10 fold, helping to prevent alveolar collapse.
  • Surfactant deficiency occurs in hyaline membrane disease (respiratory distress syndrome), especially in premature newborns.
  • Without adequate surfactant, surface tension increases, causing alveolar collapse (atelectasis) and fluid accumulation.
  • Severe surfactant deficiency leads to respiratory distress, impaired gas exchange, and may cause death if untreated.
  • Surfactant therapy, assisted ventilation, and antenatal corticosteroids have significantly improved survival, although the disease remains a major cause of morbidity and mortality in preterm infants.

Made by self learning Dr sheen

Leave a Reply

Your email address will not be published. Required fields are marked *